Review




Structured Review

Sanofi the mps i registry
The Mps I Registry, supplied by Sanofi, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/the+mps+i+registry/mps+i+registry/pmc09545955-75-5-16
Average 90 stars, based on 1 article reviews
the mps i registry - by Bioz Stars, 2026-10
90/100 stars

Images

Related Articles

other:

Article Title: Growth in individuals with attenuated mucopolysaccharidosis type I during untreated and treated periods: Data from the MPS I registry
Article Snippet: Data were obtained from The MPS I Registry (NCT00144794), an observational global longitudinal database funded by Sanofi (Cambridge, MA) and established to capture standard of care clinical and biochemical assessments of patients with MPS I and to evaluate clinical outcomes.



Similar Products

90
Genzyme mps i (idua) registry
Mps I (Idua) Registry, supplied by Genzyme, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/the+mps+i+registry/mps+i+registry/pm39426251-234-12-6
Average 90 stars, based on 1 article reviews
mps i (idua) registry - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Disease Registry mps i registry
General characteristics of selected studies.
Mps I Registry, supplied by Disease Registry, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/the+mps+i+registry/mps+i+registry/pmc10415943-10-8-19
Average 90 stars, based on 1 article reviews
mps i registry - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Sanofi the mps i registry
General characteristics of selected studies.
The Mps I Registry, supplied by Sanofi, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/the+mps+i+registry/mps+i+registry/pmc09545955-75-5-16
Average 90 stars, based on 1 article reviews
the mps i registry - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Genzyme mps i registry
General characteristics of selected studies.
Mps I Registry, supplied by Genzyme, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/the+mps+i+registry/mps+i+registry/pm33741271-279-11-15
Average 90 stars, based on 1 article reviews
mps i registry - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Sanofi mps i registry
General characteristics of selected studies.
Mps I Registry, supplied by Sanofi, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/the+mps+i+registry/mps+i+registry/pmc07151028-279-8-2
Average 90 stars, based on 1 article reviews
mps i registry - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Disease Registry mps i disease registry
General characteristics of selected studies.
Mps I Disease Registry, supplied by Disease Registry, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/the+mps+i+registry/mps+i+registry/pmc05763496-330-1-3
Average 90 stars, based on 1 article reviews
mps i disease registry - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


General characteristics of selected studies.

Journal: Journal of Medical Internet Research

Article Title: The Minimum Data Set for Rare Diseases: Systematic Review

doi: 10.2196/44641

Figure Lengend Snippet: General characteristics of selected studies.

Article Snippet: Pastores et al [ ], 2007 , The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with mucopolysaccharidosis type I , Cohort , International.

Techniques: Biomarker Discovery, Software